Takayasu's arteritis in Turkey - Clinical and angiographic features of 248 patients

Autor: Bicakcigil, M., Aksu, K., Kamali, S., Ozbalkan, Z., Ates, A., Karadag, O., Ozer, H.T.E.
Přispěvatelé: Bicakcigil, M., Aksu, K., Kamali, S., Ozbalkan, Z., Ates, A., Karadag, O., Direskeneli, H., Yeditepe Üniversitesi, Çukurova Üniversitesi
Jazyk: angličtina
Rok vydání: 2009
Předmět:
Male
Takayasu's arteritis
demography
Turkey
Comorbidity
pulmonary hypertension
erythema nodosum
angiography
Raynaud phenomenon
Prospective Studies
Age of Onset
tumor necrosis factor inhibitor
Child
fever
azathioprine
adult
Remission Induction
aorta arch syndrome
article
Middle Aged
Prognosis
aged
aorta valve regurgitation
appetite
female
arthritis
priority journal
syncope
Drug Therapy
Combination

cerebrovascular accident
headache
Immunosuppressive Agents
prospective study
corticosteroid
hypertension
Adolescent
heart infarction
disease classification
pericarditis
methotrexate
mycophenolic acid 2 morpholinoethyl ester
Young Adult
remission
turkey (bird)
blurred vision
weakness
follow up
Humans
controlled study
human
arthralgia
limb pain
Glucocorticoids
leflunomide
claudication
renal artery
carotid artery
thorax pain
dyspnea
major clinical study
subclavian artery
Takayasu Arteritis
clinical feature
kidney artery stenosis
heart palpitation
cyclophosphamide
weight reduction
clinical protocol
Clinical and angiographic features
ISSN: 1964-6348
Popis: PubMedID: 19646348 Objective. Takayasu's arteritis (TA) is a chronic, inflammatory vasculitis affecting the aorta and its major branches. Although it is more prevalent in Far-East Asia, the distribution of the disease is worldwide with different vascular involvement patterns and clinical manifestations. The objective of this study was to evaluate the demographic, clinical, angiographic and prognostic features of TA patients in Turkey. Methods. Clinical and angiographic findings of 248 TA patients (228 female, 27 male) followed at 15 Rheumatology Centers were prospectively evaluated according to a predefined protocol. Results. The mean age was 40.1 years (30.2 years at the clinical onset). Clinical manifestations included constitutional symptoms in 66%, absent or diminished pulses in 88%, bruits in 77%, extremity pain in 69%, claudication in 48%, hypertension in 43% and cerebrovascular accidents (CVA) in 18% of the patients. Renal artery stenosis, aortic regurgitation and pulmonary hypertension were present in 26%, 33% and 12%, respectively. According to the new angiographic classification, type V (50.8%) and Type I (32%) were the most frequent types of involvement. Corticosteroids were the main treatment in 93% of the patients alone (9%) or in combination with immunosuppressive agents (84%). Most frequently preferred immunosuppressive agents were methotrexate (63%), azathioprine (22%) and cyclophosphamide (13%). Remission was observed at least once in 94% of the patients and sustained remission in 71% during follow-up. Conclusion. The demographical, clinical and angiographic findings of TA patients in our series were similar to those reported from Japan, Brazil and Colombia. Combination therapies with immunosuppressive agents were the preferred choice of treatment in Turkey. © Copyright Clinical and Experimental Rheumatology 2009.
Databáze: OpenAIRE